BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8325891)

  • 1. Structure and expression of the mRNA encoding urinary stone protein (osteopontin).
    Kohri K; Nomura S; Kitamura Y; Nagata T; Yoshioka K; Iguchi M; Yamate T; Umekawa T; Suzuki Y; Sinohara H
    J Biol Chem; 1993 Jul; 268(20):15180-4. PubMed ID: 8325891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteopontin mRNA in the kidney on an experimental rat model of renal stone formation without renal failure.
    Umekawa T; Yamate T; Amasaki N; Kohri K; Kurita T
    Urol Int; 1995; 55(1):6-10. PubMed ID: 7571189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of osteopontin mRNA in normal and stone-forming rat kidney.
    Jiang XJ; Feng T; Chang LS; Kong XT; Wang G; Zhang ZW; Guo YL
    Urol Res; 1998; 26(6):389-94. PubMed ID: 9879818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Significance of macrophage and cytokines in expression of stone matrix].
    Ito T
    Nihon Hinyokika Gakkai Zasshi; 1996 May; 87(5):865-74. PubMed ID: 8691712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium oxalate crystal localization and osteopontin immunostaining in genetic hypercalciuric stone-forming rats.
    Evan AP; Bledsoe SB; Smith SB; Bushinsky DA
    Kidney Int; 2004 Jan; 65(1):154-61. PubMed ID: 14675046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular cloning and sequencing of cDNA encoding urinary stone protein, which is identical to osteopontin.
    Kohri K; Suzuki Y; Yoshida K; Yamamoto K; Amasaki N; Yamate T; Umekawa T; Iguchi M; Sinohara H; Kurita T
    Biochem Biophys Res Commun; 1992 Apr; 184(2):859-64. PubMed ID: 1575754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of osteopontin in rat kidneys: induction during ethylene glycol induced calcium oxalate nephrolithiasis.
    Khan SR; Johnson JM; Peck AB; Cornelius JG; Glenton PA
    J Urol; 2002 Sep; 168(3):1173-81. PubMed ID: 12187263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrastructural immunodetection of osteopontin and osteocalcin as major matrix components of renal calculi.
    McKee MD; Nanci A; Khan SR
    J Bone Miner Res; 1995 Dec; 10(12):1913-29. PubMed ID: 8619372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of osteopontin messenger RNA in the rat kidney on experimental model of renal stone.
    Umekawa T; Kohri K; Kurita T; Hirota S; Nomura S; Kitamura Y
    Biochem Mol Biol Int; 1995 Jan; 35(1):223-30. PubMed ID: 7735136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alendronate inhibits osteopontin expression enhanced by parathyroid hormone-related peptide (PTHrP) in the rat kidney.
    Yasui T; Fujita K; Sasaki S; Iguchi M; Hirota S; Nomura S; Azuma Y; Ohta T; Kohri K
    Urol Res; 1998; 26(5):355-60. PubMed ID: 9840346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of citrate on renal stone formation and osteopontin expression in a rat urolithiasis model.
    Yasui T; Sato M; Fujita K; Tozawa K; Nomura S; Kohri K
    Urol Res; 2001 Feb; 29(1):50-6. PubMed ID: 11310216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of allopurinol on renal stone formation and osteopontin expression in a rat urolithiasis model.
    Yasui T; Sato M; Fujita K; Ito Y; Nomura S; Kohri K
    Nephron; 2001 Feb; 87(2):170-6. PubMed ID: 11244313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effects of female sex hormones on urinary stone formation in rats.
    Iguchi M; Takamura C; Umekawa T; Kurita T; Kohri K
    Kidney Int; 1999 Aug; 56(2):479-85. PubMed ID: 10432386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of sex hormones on renal osteopontin expression and urinary constituents in experimental urolithiasis.
    Yagisawa T; Ito F; Osaka Y; Amano H; Kobayashi C; Toma H
    J Urol; 2001 Sep; 166(3):1078-82. PubMed ID: 11490302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of osteopontin on the adhesion of calcium oxalate crystals to Madin-Darby canine kidney cells.
    Yamate T; Kohri K; Umekawa T; Amasaki N; Amasaki N; Isikawa Y; Iguchi M; Kurita T
    Eur Urol; 1996; 30(3):388-93. PubMed ID: 8931975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of osteopontin and calprotectin as matrix protein in calcium-containing stone.
    Tawada T; Fujita K; Sakakura T; Shibutani T; Nagata T; Iguchi M; Kohri K
    Urol Res; 1999 Aug; 27(4):238-42. PubMed ID: 10460892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of osteopontin, a urinary inhibitor of stone mineral crystal growth, in rat kidney.
    Kleinman JG; Beshensky A; Worcester EM; Brown D
    Kidney Int; 1995 Jun; 47(6):1585-96. PubMed ID: 7643527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal osteopontin expression in experimental urolithiasis.
    Yagisawa T; Chandhoke PS; Fan J; Lucia S
    J Endourol; 1998 Apr; 12(2):171-6. PubMed ID: 9607445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of osteopontin as matrix protein in calcium-containing urinary stones.
    Yamate T; Umekawa T; Iguchi M; Kurita T; Kohri K
    Hinyokika Kiyo; 1997 Sep; 43(9):623-7. PubMed ID: 9365840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomolecular mechanism of urinary stone formation involving osteopontin.
    Kohri K; Yasui T; Okada A; Hirose M; Hamamoto S; Fujii Y; Niimi K; Taguchi K
    Urol Res; 2012 Dec; 40(6):623-37. PubMed ID: 23124115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.